Raia Drogasil S.A. (OTCMKTS:RADLY – Get Free Report)’s stock price gapped down before the market opened on Friday. The stock had previously closed at $4.01, but opened at $3.81. Raia Drogasil shares last traded at $3.80, with a volume of 747 shares.
Raia Drogasil Trading Down 9.1%
The company has a quick ratio of 0.58, a current ratio of 1.41 and a debt-to-equity ratio of 0.99. The firm’s 50-day simple moving average is $3.74 and its 200 day simple moving average is $3.86. The stock has a market capitalization of $5.00 billion and a P/E ratio of 25.33.
Raia Drogasil (OTCMKTS:RADLY – Get Free Report) last announced its earnings results on Tuesday, August 4th. The company reported $0.05 EPS for the quarter, meeting the consensus estimate of $0.05. Raia Drogasil had a return on equity of 20.12% and a net margin of 2.99%. The business had revenue of $2.17 billion during the quarter, compared to the consensus estimate of $2.32 billion. Equities research analysts anticipate that Raia Drogasil S.A. will post 0.17 EPS for the current fiscal year.
Raia Drogasil Company Profile
Raia Drogasil SA, known as RD Saúde, is a Brazilian healthcare and pharmacy retail company. It operates a nationwide network of drugstores under the Raia and Drogasil brands, offering prescription medicines, over-the-counter products, vitamins, personal-care items, cosmetics and other health-related merchandise.
The company also provides digital shopping and delivery services through its online channels, supporting customers with prescription fulfillment and access to pharmacy products.
Featured Stories
- Five stocks we like better than Raia Drogasil
- AST SpaceMobile Is Down 67%—Could SpaceX’s Mobile Push Deepen the Selloff?
- GlobalFoundries’ $21 Billion Deal Could Change the Economics of Chipmaking
- Fundamental and Technicals Signals Align for Costco: Is the Stock Finally Breaking Out?
- Palantir’s Potential Next Catalyst After Retail Profit-Taking
Receive News & Ratings for Raia Drogasil Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Raia Drogasil and related companies with MarketBeat.com's FREE daily email newsletter.
